Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.
Bad Policies Are Being Proposed by HHS Secretary Nominee Xavier Becerra
The first clue that Joe Biden, the presumptive 46th President of the United States, was choosing someone he did not know well as his nominee for secretary of HHS was when he mispronounced his name and incorrectly named the agency he would direct.
The Fourth Circuit Was Right to Reject Price Controls for Generic Drugs
This prudent decision will send a strong message to other state legislatures across the country not to pursue similar legislation.
Vote NO on AB 215 – Pharmaceutical – Nevada
Nevada State Assembly 401 South Carson Street Carson City, Nevada 89701-4747 Dear Assembly Member, AB 215, a so-called pharmaceutical price transparency bill, was introduced on February 13, 2017 and is currently being considered by the Assembly Committee on Health and Human Services. It would require pharmaceutical companies to provide to the Division of Insurance an […]
Newt’s Very Bad Idea
Former House Speaker Newt Gingrich often comes up with ideas to change how the government works. One of his most recent suggestions has made a lot of people who care about property rights scratch their head. At a December 2, 2014 meeting of Academy of Managed Care Pharmacy executives, Speaker Gingrich was asked about the […]
What is the 340B Program and Why You Need to Care
Problems in the 340B drug discount program are growing and costs are increasing due as more entities participate in the program.